Iowa State Bank Has $3.55 Million Stock Position in MetLife, Inc. (NYSE:MET)

Iowa State Bank reduced its stake in MetLife, Inc. (NYSE:METFree Report) by 1.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 53,661 shares of the financial services provider’s stock after selling 1,033 shares during the quarter. Iowa State Bank’s holdings in MetLife were worth $3,549,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. FWL Investment Management LLC acquired a new position in shares of MetLife in the fourth quarter worth approximately $26,000. DHJJ Financial Advisors Ltd. acquired a new position in MetLife in the third quarter valued at approximately $25,000. Studio Investment Management LLC bought a new position in shares of MetLife during the 4th quarter worth approximately $29,000. Planned Solutions Inc. bought a new position in shares of MetLife during the 4th quarter worth approximately $28,000. Finally, Eagle Bay Advisors LLC bought a new position in shares of MetLife during the 2nd quarter worth approximately $28,000. 89.81% of the stock is owned by institutional investors and hedge funds.

MetLife Stock Down 0.6 %

NYSE MET traded down $0.46 on Tuesday, reaching $73.23. The company had a trading volume of 2,320,072 shares, compared to its average volume of 3,730,195. The stock has a market capitalization of $52.95 billion, a P/E ratio of 40.02, a P/E/G ratio of 0.56 and a beta of 1.04. The company’s fifty day moving average is $70.19 and its 200 day moving average is $66.09. MetLife, Inc. has a 52-week low of $48.95 and a 52-week high of $74.39. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.53.

MetLife (NYSE:METGet Free Report) last released its quarterly earnings results on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.02). The company had revenue of $18.72 billion during the quarter, compared to analysts’ expectations of $18.07 billion. MetLife had a net margin of 2.36% and a return on equity of 19.48%. Sell-side analysts anticipate that MetLife, Inc. will post 8.81 earnings per share for the current fiscal year.

MetLife Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 14th. Investors of record on Tuesday, February 6th were given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.84%. The ex-dividend date was Monday, February 5th. MetLife’s payout ratio is currently 113.66%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on MET. The Goldman Sachs Group upgraded MetLife from a “neutral” rating to a “buy” rating and increased their price target for the stock from $70.00 to $80.00 in a report on Monday, January 8th. Keefe, Bruyette & Woods cut their price target on MetLife from $79.00 to $77.00 and set an “outperform” rating on the stock in a report on Thursday, December 7th. UBS Group lowered their target price on MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a research report on Monday, February 5th. Finally, Wells Fargo & Company lowered their target price on MetLife from $85.00 to $83.00 and set an “overweight” rating on the stock in a research report on Tuesday, February 6th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $77.23.

View Our Latest Report on MetLife

Insider Buying and Selling at MetLife

In other MetLife news, EVP Bill Pappas sold 27,000 shares of the company’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $72.27, for a total value of $1,951,290.00. Following the completion of the transaction, the executive vice president now owns 57,768 shares in the company, valued at approximately $4,174,893.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other MetLife news, insider Ramy Tadros sold 4,026 shares of the company’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the transaction, the insider now owns 146,981 shares in the company, valued at approximately $10,567,933.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Bill Pappas sold 27,000 shares of the stock in a transaction on Monday, March 18th. The stock was sold at an average price of $72.27, for a total value of $1,951,290.00. Following the transaction, the executive vice president now owns 57,768 shares of the company’s stock, valued at approximately $4,174,893.36. The disclosure for this sale can be found here. Corporate insiders own 0.32% of the company’s stock.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.